中文产业新闻评分60Chinese source
FDA批准Lantheus靶向Tau的PET示踪剂TAUKLARIFY用于阿尔茨海默病评估
Lantheus ：TAUKLARIFY™获FDA批准，全新Tau‑PET示踪剂助力阿尔茨海默病评估
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
Lantheus ：TAUKLARIFY™获FDA批准，全新Tau‑PET示踪剂助力阿尔茨海默病评估
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.